Home – CDMO Solutions | Our Approach | Ways to work with us
Partner with OXB for Cell and Gene Therapy Development and Manufacturing
With over 30 years’ developing viral vectors, we understand that each phase of development has different requirements, which is why we offer a range of development pathways to our partners.
Flexible collaboration models for cell and gene therapy development
At OXB, we offer a range of partnership models designed to meet you where you are in your cell and gene therapy journey. Whether you're looking to leverage our proprietary platforms, tailor a custom solution, or transfer in your existing process, we provide the scientific expertise, technical infrastructure, and collaborative spirit to help you succeed.
Platform project
For clients that are pre-clinical or early-clinical that wish to reach GMP at an accelerated rate with a proven process.
Custom solution
For clients that are pre-clinical or early-clinical that require flexibility in the manufacture of their drug candidate.
Tech-transfer
For clients in phase I, II, or III that need to transfer their manufacture to a CDMO for scale and/or long-term manufacture.
Platform projects: Accelerate with proven technology
Harness the power of our proprietary LentiVector™ and inAAVate™ platforms to fast-track your therapy development
By choosing a platform project, you gain access to our end-to-end capabilities. Platform projects include full lifecycle support - from vector engineering and process development through GMP manufacturing and regulatory documentation, accelerating timelines and de-risking development.
LentiVector™ platform
Our proprietary lentiviral vector platform with a strong track record in delivering gene-modified cell therapies. The platform includes scalable upstream and downstream processes, high-titer production, and comprehensive analytical characterisation.
inAAVate™ platform
Our next-generation AAV platform, designed for scalable, high-yield production and optimised transduction efficiency. The platform uses a dual-plasmid system which together with our proprietary transfection process increases bioreactor vg titer up to 10-fold over current industry standard.
Custom solutions: Build your own path with our toolboxes
Every therapy is unique. That’s why we offer custom solutions - flexible, modular approaches that allow you to select only the services you need.
This model gives you the freedom to innovate while leveraging OXB’s deep expertise and infrastructure.
Custom solutions
Choose from vector design, analytical development, process optimization, GMP manufacturing, and more.
Bespoke development
Combine our capabilities and technologies with your own to create a bespoke development and manufacturing strategy.
Tailored support
Ideal for clients seeking tailored support without committing to a full platform programme, or those with unique IP requirements.
Tech-transfer: Seamless integration of your process
Already have a process in place? We make it easy to bring it to OXB.
This model is perfect for clients looking to scale up or commercialise their therapy with a reliable, high-quality manufacturing partner.
Transfer-in
Transfer in your existing process and benefit from our state-of-the-art facilities and experienced technical teams.
Smooth transition
We ensure a smooth transition with robust tech transfer protocols, risk mitigation strategies, and collaborative project management.
Maintain control
Maintain control of your process while gaining a trusted partner to scale and manufacture with confidence.
Let’s deliver life-changing therapies together
With over 30 years of experience in viral vector development and manufacturing, OXB is a trusted partner for cell and gene therapy innovators worldwide. Whether you're starting from scratch or scaling an existing process, OXB is here to help you bring your therapy to life. Explore our partnership models and discover how we can work together to deliver life-changing therapies to patients around the world.
